Combination therapy with Corvitin and Axotilin in the treatment of patients with ischemic stroke

T.S. Mishchenko, O.V. Dmytriieva


The article deals with the therapy of ischemic stroke. Attention is paid to the use of drugs with a multimodal effect. The results of the study on the efficacy and tolerability of combined neuroprotective therapy using Corvitin and Axotilin in the acute stage of cerebral ischemic stroke are presented. A statistically significant positive effect of combined neuroprotective therapy with the above-mentioned drugs on the severity of neurologic disorders, restoration of cognitive functions was established, and a decrease in the degree of disability of patients compared with the control group was noted.


ischemic stroke; acute stage of stroke; combination therapy; neuroprotective therapy


Міщенко Т.С. Стан неврологічної служби в Україні за 2016 рік. — 2017. — 20 с.

Heart and Stroke Foundation. Together against a rising tide: advancing stroke systems of care. Stroke Month Report 2014. Ottawa, ON, Heart and Stroke Foundation, (2014, accessed 5 April 2015).

Ovbiagele B., Goldstein L.B. Higashida R.T. et al. Forecas­ting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association // Stroke. — 2013. — 44. — 2361-75.

Secades J.J., Lorenzo J.L. Citicoline: Pharmacological and clinical review, 2006 Update // Methods Find Exp. Clin. Pharmacol. — 2006. — 28 (Suppl. B). — 1-56.

Adibhatla A.M., Hatcher J.F., Larsen E.C. Cytokine biology, li­pid metabolism and citicoline in stroke // J. Cereb. Blood Flow Metab. — 2007. — 27 (Suppl. I). — B06-B02.

Adibhatla R.M., Hatcher J.F. Role of lipids in brain injury and diseases // Future Upidol. — 2007. — 2. — 403-422.

Adibhatla R.M., Hatcher J.F. Lipid oxidation and peroxidation in CNS health and disease; from molecular mechanisms to therapeutic opportunities // Antioxid. Redox. Signal. — 2010. — 12. — 125-169.

Clark W.M., Warach S.J., Pettigrew L.C., Gammans R.E., Sa­bounjian L.A. A randomised dose-response trial of citicoline in acute ischemic stroke patients // Neurology. — 1997. — 49. — 671-678.

Clark W.M., Williams B.J., Selzer K.A., Zweifler R.M., Sa­bounjian L.A., Gammans R.E. A randomized efficacy trial of citicoline in patients with acute ischemic stroke // Stroke. — 1999. — 30. — 2592-2597.

Warach S., Pettigrew L.C., Dashe J.F., Pullicino P., Lefko­witz D.M., Sabounjian L., Harnett K., Schwidcrski U., Gammans R. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging // Ann. Neurol. — 2000. — 48. — 713-722.

Clark W.M., Wechsler L.R., Sabounjian L.A., Schwiderski U.E. For the Citicoline Stroke Study Group. A phase III randomi­zed efficacy trial of 2000 mg citicoline in acute ischemic stroke patients // Neurology. — 2001. — 57. — 1595-1602.

Warach S.J., Sabounjian L.A. ECCO 2000 study of citicoline for treatment of acute ischemic stroke: effects on infarct volumes measured by MRI // Stroke. — 2000. — 31. — 283. Abstract.

Sobrino Т., Hurtado О., Моrо М.L., Rodriguez-Ydnez M., Castellanos M., Brea D., Moldes O., Blanco M., Areniltas J.F., Leira R., Davalos A., Lizasoain Castillo J. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome // Stroke. — 2007. — 38. — 2759-2764.

Sobrino Т., Rodriguez-Gonzalez R., Blanco M., Brea D. et al.

CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke // Neurol. Res. — 2010. — In press.

Saver J.L. Citicoline: update on a promising and widely avai­lable agent for neuroprotection and neurorepair // Rev. Neurol. Dis. — 2008. — 767-777.

Ortega G., Jacas C., Quintana M., Ribo M., Santamarina E., Maisterra О., Molina C., Montaner J., Roman G., Alvarez-Sabin J. Citicoline treatment prevents neurocognitive decline after a first ischemic stroke // Cerebrovasc. Dis. — 2010. — 29 (Suppl. 2). — 268.

Arakawa S., Реrеrа N., Donnan G.A. Neuroprotection in stroke // ACNR. — 2005. — № 5 (5). — P. 10-11.

Барабой B.A. Биоантиоксиданты. — К.: Книга плюс, 2006. — 461 с.

Эндогенные механизмы кардиопротекции как основа патогенетической терапии заболеваний сердца / Под ред. А.А. Мойбенко. — К.: Наукова думка, 2008. — 511 с.

Di Paolo G., De Camilli P. Phosphoinositides in cell regulation and membrane dynamics // Nature. — 2006. — Vol. 12. — P. 651-657.

Румянцева С.А., Оганов Р.Г., Силина Е.В., Ступин В.А. и соавт. Современные концепции лечения пациентов с сосудистой коморбидностью. Часть 1. Коррекция тканевого энергодефицита // Кардиоваскулярная терапия и профилактика. — 2012. — 11 (6). — С. 44-49.

Виничук С.М., Прокопив М.М., Черенько Т.М. Поиск новых подходов к лечению острого ишемического инсульта // Український неврологічний журнал. — 2010. — № 1. — С. 8-19.

Виничук С.М. Применение нового отечественного препарата Корвитин в лечении острого ишемического инсульта // Практична ангіологія. — 2010. — № 4 (33). — С. 12-19.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2020


   Seo анализ сайта